Oklo Inc vs Koninklijke Philips NV — how do they compare? Oklo Inc trades at $44.41 (market cap $7.68B), while Koninklijke Philips NV trades at $26.3 (market cap $25.89B). The key difference: Koninklijke Philips NV is far larger — about 3.4× Oklo Inc's market cap, and Koninklijke Philips NV pays a 3.81% dividend while Oklo Inc pays none. Which is the better fit depends on your goals.
| OKLO | PHG | |
|---|---|---|
Market Cap | $7.68B | $25.89B |
Sector | Technology | Health |
52-Week High | $174.14 | $32.91 |
52-Week Low | $41.11 | $25.02 |
Enterprise Value | $5.47B | $32.18B |
Dividend Yield | — | 3.81% |
Signals from Pluang's Aura AI — not financial advice
OKLO trades at $41.51, up 0.97% today but remains in a significant downtrend with a 42% decline year-to-date. The stock shows bearish technical signals with negative profitability metrics including -8.87% ROE and consistent quarterly losses. Recent news highlights participation in a government nuclear power program for AI data centers, providing potential catalysts amid ongoing regulatory challenges and execution risks.
Despite analyst optimism with a $90.88 consensus target representing 119% upside, OKLO faces substantial execution and regulatory hurdles. The company burns significant cash with -$138.77M EBITDA while relying on financing activities. Long-term potential exists in nuclear energy demand, but near-term volatility and losses require careful risk assessment for investors.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Oklo Inc. is a company focused on developing and commercializing advanced fission power plants. The company specializes in micro-reactor technology, specifically the Aurora design, which uses advanced fuel to produce reliable, clean, and cost-competitive power. Oklo aims to provide scalable, on-site power solutions to various customers, including remote communities, industrial facilities, and government entities, positioning itself as an innovator in the next generation of nuclear energy.
Read more on OKLO →Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →